10:51 AM EST, 12/04/2024 (MT Newswires) -- Zimmer Biomet ( ZBH ) said Wednesday that the US Food and Drug Administration granted 510 (k) clearance to Persona SoluTion Porous Plasma Spray Femur.

The total knee implant, which features a porous coating for cementless fixation, offers an option for patients with sensitivities to bone cement and/or metal, according to the company.

The company said Persona SoluTion PPS Femur will be commercially available in the US in Q1.

Shares of Zimmer Biomet ( ZBH ) were up 1% in recent trading.

Price: 111.86, Change: +1.12, Percent Change: +1.01